News

Celebrating Innovation: ULP's I-CREATE Showcase Highlights

Celebrating Innovation: ULP's I-CREATE Showcase Highlights

Celebrating Innovation in MedTech with ULP's I-CREATE Awards

University Lab Partners (ULP) recently celebrated the inspiring winners of its inaugural I-CREATE Showcase. This event highlighted nine outstanding MedTech startups presenting their innovative solutions to a panel comprising investors, industry leaders, and health experts, marking a significant stride in the medical technology sector.

Winners of the I-CREATE Showcase

Among the distinguished winners, three companies stood out for their exceptional contributions:

  • $50,000 Prize - Acorn Genetics
  • $30,000 Prize - Latde Diagnostics
  • $20,000 Prize - Mitos Diagnostics

These companies showcased unique and compelling health solutions focused on enhancing health security and addressing critical challenges in the medical diagnostics field.

Feedback from Awardees

"Participating in the I-CREATE accelerator was a turning point for our team, allowing us to enhance our strategy and accelerate our progress significantly," said Ana Cornell, CEO of Acorn Genetics. She emphasized the importance of the support received from ULP and the broader I-CREATE network, which were vital for establishing essential connections and getting their technology ready for impactful use in the real world.

Accelerator Program Overview

All participating startups underwent an extensive six-month accelerator program featuring tailored workshops, expert consulting, and mentorship aimed at fostering growth and innovation. During the showcase, additional companies like Checktor Biosciences, VIDEM, and Hikari Medical Technology were awarded $5,000 in consulting services to further advance their technologies.

The Role of I-CREATE in Medical Innovation

The I-CREATE (International Consortium for Research, Engineering, Acceleration of Technology Excellence) program, a part of the BARDA Accelerator Network, plays a crucial role in advancing medical devices and diagnostics by partnering with CIMIT and Science Exchange. This initiative aims to bridge gaps in the healthcare sector by supporting emerging enterprises focused on developing life-changing innovations.

Stephanie Chan, PhD, the Program Officer of I-CREATE at ULP, commented on the astonishing level of innovation displayed in this first cohort. She expressed pride in the entrepreneurs who are actively working to shape the global health security landscape, and ULP is honored to support their journeys.

Applications Open for the Next Cohort

ULP is excited to announce that applications are currently open for the next I-CREATE cohort, offering substantial opportunities for growth:

  • Up to $200,000 in non-dilutive funding for top applicants
  • Customized mentorship, technical consulting, and investment opportunities
  • A chance to contend for a $50,000 grand prize

Startups focusing on medical devices or diagnostic technologies that address urgent public health threats are encouraged to apply. Applications will be accepted on a rolling basis until mid-2025.

About I-CREATE

I-CREATE provides a pathway for innovative advancements in medical devices and diagnostic solutions. By connecting startups with a rich network of investors and industry veterans, I-CREATE equips entrepreneurs to navigate the complexities of product development and market entry, aiming to foster impactful medical countermeasures that cater to pressing health needs.

About University Lab Partners

University Lab Partners (ULP), a top-tier nonprofit wet lab incubator nestled in California, offers advanced lab spaces and nurtures a dynamic community of innovators focused on life sciences. Beyond providing state-of-the-art facilities, ULP runs global accelerator programs and workforce development initiatives, thereby promoting innovation and supporting the ecosystem of life sciences worldwide.

Frequently Asked Questions

What is the I-CREATE program?

The I-CREATE program supports MedTech startups by providing access to funding, mentorship, and resources to enhance product development and market readiness.

Who won the I-CREATE Showcase?

The winners included Acorn Genetics, Latde Diagnostics, and Mitos Diagnostics, each recognized for their innovative health solutions.

How can startups apply for the next I-CREATE cohort?

Startups can apply online through ULP's website, with applications accepted on a rolling basis until approximately mid-2025.

What kind of support does I-CREATE offer?

I-CREATE provides extensive support, including funding opportunities, mentorship programs, and expert consultations tailored to each startup’s needs.

Why is ULP significant for MedTech innovation?

ULP plays a critical role in fostering MedTech innovation by offering resources, networking opportunities, and a nurturing environment for emerging companies in the life sciences field.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading